GBA Presents: House of Gummy-!

Discussion in 'Stocks' started by stonedinvestor, May 13, 2023.

  1. Arista slides after Nvidia discusses networking ambitions » 12:59 NVDA, ANET, CSCO :wtf:
     
    #18211     May 23, 2024
    Darc likes this.


  2. [​IMG]






     
    #18212     May 23, 2024
    Darc likes this.
  3. Van conquered the Widow Maker, all in a day’s work for the Savant!
     
    #18213     May 23, 2024
    GreatCamel likes this.
  4. GreatCamel

    GreatCamel

    #18214     May 23, 2024
  5. vanzandt

    vanzandt

    I have 3 of the wday $255p's at $5 for earnings.
     
    #18215     May 23, 2024
    TrailerParkTed likes this.
  6. vanzandt

    vanzandt


     
    #18216     May 23, 2024
    stonedinvestor and GreatCamel like this.
  7. Man it sure feels like the fool on the hill invested on the day stocks turned around./

    o_O That Lizard King he would be so short right now if he could find me.... o_O

    Alert****--> COVID SPIKING!!! FLIRT variant !!! FDA meeting canceled...
     
    #18217     May 23, 2024
    Darc likes this.
  8. vanzandt

    vanzandt

    out... It could gap up.
     
    #18218     May 23, 2024


  9. Workday options imply 4.6% move in share price post-earnings » 13:04 WDAY
     
    #18219     May 23, 2024
    Darc likes this.
  10. The worry is that newly emerging versions of the virus could change things. The FLiRT variants are descended from omicron, and have mutations in the spike protein that make them more easily transmissible, according to experts. The group of variants, which include KP.1.1 and KP.2, are named after the troubling mutations responsible for the extra transmissibility, the F456L and R346T mutations.

    It all involves a lot of confusing letters and numbers. This winter, JN.1 was the dominant strain. By April 22, its descendent KP.2 variations with the FLiRT mutations accounted for over 40% of global prevalence, according to the UK health analytics firm Airfinity. KP.2 accounts for 28% of US cases, according to CDC data.

    KP.2s growing prevalence was enough to give the FDA a reason to postpone their periodic vaccine meeting from May 16 to June 5. Ahead of flu season, the FDA wants to reevaluate whether the next round of Covid boosters should protect against KP or JN or both.

    As of now the World Health Organization and the European Medicines Agency are recommending vaccines for the earlier variant. The FDA Is likely weighing whether its vaccine recommendation should include protection for the current dominant strain in the fall and winter, an Airfinity analysis said.

    This is not an easy decision for regulators. They have to weigh whether to prioritize a quicker vaccine delivery with the broadest protection or a recommendation that could protect against future subvariants with delivery delays of up to four months.
     
    #18220     May 23, 2024
    Darc likes this.